Probiotic composition for use in the prevention of birth-acquired bacterial and fungal infections in newborns
EP3086798A1
Formulations based on astragaloside iv or extracts containing it for the prevention and treatment of insomnia and jet-lag-related disorders
EP2908828A1
Galactagogue compositions based on phosphatidylserine
EP2685967A1
Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e
EP2228062A1
Compositions containing a phospholipid-curcumin complex and piperine as chemosensitizing agent
EP2149378A1
Topical formulations for the symptomatic treatment of musculoskeletal disorders
EP2149369A1
Instant oral formulations, gelling at room temperature, useful to treat physical wasting and the depressive syndrome associated with cachexia, anorexia, metabolic disorders, endocrine disorders and dysphagia
EP2149377A1
Compositions containing berberine or extracts containing it, for the prevention and treatment of alterations of the lipid and carbohydrate balance
EP2252279A1
Amino acid formulations comprising cysteine, methionine and serine for the prevention of paracetamol-induced liver damage
EP2014295A2
Topical compositions for the prevention and treatment of inflammatory and/or infective conditions of the genital area
EP2087900A1
Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antogonist terpenic fraction, and compostions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
EP1917969A1
Compositions for preventing depletion of the intestinal flora and organ damage following antibiotic treatment
